The biggest opportunity to improve lung cancer survival isn’t a new drug
Chris Wood, CEO of RevealDx, reflects on the role AI-based characterisation of nodules (CADx) has to play in improving lung cancer survival rates.
Chris Wood, CEO of RevealDx, reflects on the role AI-based characterisation of nodules (CADx) has to play in improving lung cancer survival rates.